These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma. Yu T, Han C, Zhu G, Liao X, Qin W, Yang C, Liu Z, Su H, Liu X, Yu L, Liu Z, Lu S, Chen Z, Liang Y, Huang J, Qin X, Gui Y, Li J, Peng T. Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708 [Abstract] [Full Text] [Related]
6. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma. Cheong JY, Shin HD, Cho SW, Kim YJ. J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584 [Abstract] [Full Text] [Related]
7. Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B. Chanthra N, Payungporn S, Chuaypen N, Piratanantatavorn K, Pinjaroen N, Poovorawan Y, Tangkijvanich P. Asian Pac J Cancer Prev; 2015 Nov; 16(18):8405-10. PubMed ID: 26745093 [Abstract] [Full Text] [Related]
8. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients. Al-Qahtani AA, Al-Anazi M, Abdo AA, Sanai FM, Al-Hamoudi W, Alswat KA, Al-Ashgar HI, Khalaf N, Viswan N, Al-Ahdal MN. Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040 [Abstract] [Full Text] [Related]
9. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, Zhang H, Cao G. Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206 [Abstract] [Full Text] [Related]
10. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM. Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522 [Abstract] [Full Text] [Related]
11. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma. Zhang QX, Li SL, Yao YQ, Li TJ. Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304 [Abstract] [Full Text] [Related]
12. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations. Liu W, Wu J, Yang F, Ma L, Ni C, Hou X, Wang L, Xu A, Song J, Deng Y, Xian L, Li Z, Wang S, Chen X, Yin J, Han X, Li C, Zhao J, Cao G. Clin Cancer Res; 2019 Sep 15; 25(18):5525-5536. PubMed ID: 31152021 [Abstract] [Full Text] [Related]
13. Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B. Chanthra N, Payungporn S, Chuaypen N, Pinjaroen N, Poovorawan Y, Tangkijvanich P. Asian Pac J Cancer Prev; 2015 Sep 15; 16(12):5069-73. PubMed ID: 26163643 [Abstract] [Full Text] [Related]
14. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study. Jeng JE, Wu HF, Tsai MF, Tsai HR, Chuang LY, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Tsai JF. Asian Pac J Cancer Prev; 2014 Sep 15; 15(23):10209-15. PubMed ID: 25556449 [Abstract] [Full Text] [Related]
15. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma]. Park JS, Cheong JY, Kang JK, Cho JH, Yu S, Shin HD, Park BL, Cho SW. Korean J Gastroenterol; 2007 Nov 15; 50(5):313-8. PubMed ID: 18159163 [Abstract] [Full Text] [Related]
16. β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma. Lu LC, Shao YY, Lee YH, Hsieh MS, Hsiao CH, Lin HH, Kao HF, Ma YY, Yen FC, Cheng AL, Hsu CH. Oncology; 2014 Nov 15; 87(3):159-66. PubMed ID: 25012536 [Abstract] [Full Text] [Related]
17. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia. Suarez M I, Uribe D, Jaramillo CM, Osorio G, Perez JC, Lopez R, Hoyos S, Hainaut P, Pineau P, Navas MC. Ann Hepatol; 2015 Nov 15; 14(1):64-74. PubMed ID: 25536643 [Abstract] [Full Text] [Related]
18. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N. J Viral Hepat; 2007 Dec 15; 14(12):841-8. PubMed ID: 18070287 [Abstract] [Full Text] [Related]
19. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features. Kawai-Kitahata F, Asahina Y, Tanaka S, Kakinuma S, Murakawa M, Nitta S, Watanabe T, Otani S, Taniguchi M, Goto F, Nagata H, Kaneko S, Tasaka-Fujita M, Nishimura-Sakurai Y, Azuma S, Itsui Y, Nakagawa M, Tanabe M, Takano S, Fukasawa M, Sakamoto M, Maekawa S, Enomoto N, Watanabe M. J Gastroenterol; 2016 May 15; 51(5):473-86. PubMed ID: 26553052 [Abstract] [Full Text] [Related]
20. TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence. Kim JH, Yu SJ, Park BL, Cheong HS, Pasaje CF, Bae JS, Lee HS, Shin HD, Kim YJ. Dig Dis; 2011 May 15; 29(3):278-83. PubMed ID: 21829018 [Abstract] [Full Text] [Related] Page: [Next] [New Search]